$BGLC
BioNexus Gene Lab Corp Stock $bglc

$bglc Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000147793224007332 Filed on November 15, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q3
Revenue		$2.630M	$2.554M
YoY Change		3.0%	-0.83%
Cost Of Revenue		$2.304M	$2.199M
YoY Change		4.75%	-3.35%
Gross Profit		$326.5K	$354.3K
YoY Change		-7.85%	18.31%
Gross Profit Margin		12.41%	13.88%
Selling, General & Admin		$2.130M	$3.081M
YoY Change		-30.88%	635.66%
% of Gross Profit		652.21%	869.53%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$34.27K	$23.15K
YoY Change		48.03%	6.83%
% of Gross Profit		10.5%	6.53%
Operating Expenses		$1.655M	$2.882M
YoY Change		-42.57%	690.16%
Operating Profit		-$1.338M	-$2.527M
YoY Change		-47.08%	3775.58%
Interest Expense		$6.193K	-$4.260K
YoY Change		-245.38%	105.8%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income		-$1.344M	-$2.532M
YoY Change		-46.92%	3662.58%
Income Tax		$1.555K	$76.42K
% Of Pretax Income
Net Earnings		-$1.345M	-$2.608M
YoY Change		-48.42%	3269.65%
Net Earnings / Revenue		-51.15%	-102.13%
Basic Earnings Per Share
Diluted Earnings Per Share		-$0.07	-$0.15
COMMON SHARES
Basic Shares Outstanding	17.97M shares	17.97M shares	17.70M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.062M	$4.705M
YoY Change	-56.18%	883.9%
Cash & Equivalents	$4.137M	$6.147M
Short-Term Investments
Other Short-Term Assets	$2.076M	$1.442M
YoY Change	43.92%	46.54%
Inventory	$1.389M	$1.108M
Prepaid Expenses
Receivables	$1.425M	$900.4K
Other Receivables	$87.82K	$114.6K
Total Short-Term Assets	$7.039M	$8.270M
YoY Change	-14.88%	52.89%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.729M	$1.644M
YoY Change	5.12%	14.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.994M	$1.551M
YoY Change	28.56%	67.88%
Other Assets
YoY Change
Total Long-Term Assets	$3.956M	$3.196M
YoY Change	23.78%	33.75%
TOTAL ASSETS
Total Short-Term Assets	$7.039M	$8.270M
Total Long-Term Assets	$3.956M	$3.196M
Total Assets	$11.00M	$11.47M
YoY Change	-4.1%	47.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.033M	$1.600M
YoY Change	-35.42%	25.11%
Accrued Expenses	$48.21K	$33.90K
YoY Change	42.21%	187.78%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.415M	$1.644M
YoY Change	-13.94%	23.16%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$178.4K	$104.9K
YoY Change	70.09%
Total Long-Term Liabilities	$192.0K	$104.9K
YoY Change	83.1%	164.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.415M	$1.644M
Total Long-Term Liabilities	$192.0K	$104.9K
Total Liabilities	$1.607M	$1.778M
YoY Change	-9.61%	29.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.094M
YoY Change
Common Stock	$17.33M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.388M	$9.688M
YoY Change
Total Liabilities & Shareholders Equity	$11.00M	$11.47M
YoY Change	-4.1%	47.03%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	-$1.345M	-$2.608M
YoY Change	-48.42%	3269.65%
Depreciation, Depletion And Amortization	$34.27K	$23.15K
YoY Change	48.03%	6.83%
Cash From Operating Activities	-$1.460M	-$899.7K
YoY Change	62.22%	-392.92%
INVESTING ACTIVITIES
Capital Expenditures	$199.2K	$138.5K
YoY Change	43.86%	-3883.06%
Acquisitions
YoY Change
Other Investing Activities	$16.07K	-$230.4K
YoY Change	-106.98%	-1146.14%
Cash From Investing Activities	-$183.1K	-$358.8K
YoY Change	-48.97%	-2054.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-199.4K	5.743M
YoY Change	-103.47%
NET CHANGE
Cash From Operating Activities	-1.460M	-899.7K
Cash From Investing Activities	-183.1K	-358.8K
Cash From Financing Activities	-199.4K	5.743M
Net Change In Cash	-1.842M	4.485M
YoY Change	-141.07%	1277.75%
FREE CASH FLOW
Cash From Operating Activities	-$1.460M	-$899.7K
Capital Expenditures	$199.2K	$138.5K
Free Cash Flow	-$1.659M	-$1.038M
YoY Change	59.77%	-434.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	bglc	Year End Us Myr Exchange Rate YearEndUsMyrExchangeRate	4.1220
CY2023	bglc	Year End Us Myr Exchange Rate YearEndUsMyrExchangeRate	4.5900
CY2023Q4	us-gaap	Trade Receivables Held For Sale Net Not Part Of Disposal Group TradeReceivablesHeldForSaleNetNotPartOfDisposalGroup	2107182	usd
CY2024Q3	us-gaap	Securities Borrowed Allowance For Credit Loss SecuritiesBorrowedAllowanceForCreditLoss	596332	usd
CY2023Q4	us-gaap	Securities Borrowed Allowance For Credit Loss SecuritiesBorrowedAllowanceForCreditLoss	1314427	usd
CY2024Q3	bglc	Fair Values Option Aggregate Differences Loans And Long Term Receivables FairValuesOptionAggregateDifferencesLoansAndLongTermReceivables	50913	usd
CY2023Q4	bglc	Fair Values Option Aggregate Differences Loans And Long Term Receivables FairValuesOptionAggregateDifferencesLoansAndLongTermReceivables	-6919	usd
CY2024Q3	us-gaap	Trade And Loans Receivables Held For Sale Net Not Part Of Disposal Group TradeAndLoansReceivablesHeldForSaleNetNotPartOfDisposalGroup	1425343	usd
CY2023Q4	us-gaap	Trade And Loans Receivables Held For Sale Net Not Part Of Disposal Group TradeAndLoansReceivablesHeldForSaleNetNotPartOfDisposalGroup	799674	usd
CY2024Q3	bglc	Trade Receivables Allowance Beginning TradeReceivablesAllowanceBeginning	1307508	usd
CY2023Q4	bglc	Trade Receivables Allowance Beginning TradeReceivablesAllowanceBeginning	0	usd
CY2024Q3	bglc	Impacts Arising From Application Trade Receivables Allowance ImpactsArisingFromApplicationTradeReceivablesAllowance	0	usd
CY2023Q4	bglc	Impacts Arising From Application Trade Receivables Allowance ImpactsArisingFromApplicationTradeReceivablesAllowance	371627	usd
CY2024Q3	bglc	Trade Receivables Allowance Restated TradeReceivablesAllowanceRestated	1307508	usd
CY2023Q4	bglc	Trade Receivables Allowance Restated TradeReceivablesAllowanceRestated	371627	usd
CY2024Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	853686	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	942800	usd
CY2024Q3	bglc	Recovered For Expected Credit Losses RecoveredForExpectedCreditLosses	-1571782	usd
CY2023Q4	bglc	Recovered For Expected Credit Losses RecoveredForExpectedCreditLosses	0	usd
CY2024Q3	us-gaap	Fair Value Option Aggregate Differences Loans And Long Term Receivables FairValueOptionAggregateDifferencesLoansAndLongTermReceivables	57832	usd
CY2023Q4	us-gaap	Fair Value Option Aggregate Differences Loans And Long Term Receivables FairValueOptionAggregateDifferencesLoansAndLongTermReceivables	-6919	usd
CY2024Q3	bglc	Trade Receivables Allowance Ending TradeReceivablesAllowanceEnding	647244	usd
CY2023Q4	bglc	Trade Receivables Allowance Ending TradeReceivablesAllowanceEnding	1307508	usd
CY2024Q3	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	0	usd
CY2023Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	0	usd
CY2024Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	13646	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	12255	usd
CY2024Q3	bglc	Income Taxs Liability IncomeTaxsLiability	-8486	usd
	bglc	Addition Of Right Of Useliabilities AdditionOfRightOfUseliabilities	142865	usd
CY2023	bglc	Addition Of Right Of Useliabilities AdditionOfRightOfUseliabilities	113279	usd
	bglc	Accumulated Amortization Of Lease AccumulatedAmortizationOfLease	-35507	usd
CY2023	bglc	Accumulated Amortization Of Lease AccumulatedAmortizationOfLease	-25038	usd
	bglc	Foreign Translation Differences ForeignTranslationDifferences	8604	usd
CY2023	bglc	Foreign Translation Differences ForeignTranslationDifferences	-2427	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	232747	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	141544	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	35507	usd
	bglc	Operating Cash Flow From Operating Lease OperatingCashFlowFromOperatingLease	-24342	usd
CY2023	bglc	Operating Cash Flow From Operating Lease OperatingCashFlowFromOperatingLease	76620	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	232747	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	141544	usd
	bglc	Finite Lived Intangibles Asset Useful Life FiniteLivedIntangiblesAssetUsefulLife	P4Y8M1D
CY2023	bglc	Finite Lived Intangibles Asset Useful Life FiniteLivedIntangiblesAssetUsefulLife	P4Y6M
	bglc	Weighted Average Discount Rate For Operating Lease WeightedAverageDiscountRateForOperatingLease	0.0665	pure
CY2023	bglc	Weighted Average Discount Rate For Operating Lease WeightedAverageDiscountRateForOperatingLease	0.0653	pure
	us-gaap	Operating Lease Expense OperatingLeaseExpense	8360	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	3311	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2396622	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	729247	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	659115	usd
CY2024Q3	bglc	Add Foreign Translation Differences AddForeignTranslationDifferences	-47204	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1728680	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1511618	usd
	us-gaap	Depreciation Depreciation	74611	usd
	us-gaap	Depreciation Depreciation	63147	usd
	bglc	Other Investments Beginning Balance OtherInvestmentsBeginningBalance	1699831	usd
CY2023	bglc	Other Investments Beginning Balance OtherInvestmentsBeginningBalance	1150898	usd
	bglc	Addition During The Year AdditionDuringTheYear	486170	usd
CY2023	bglc	Addition During The Year AdditionDuringTheYear	320733	usd
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-459642	usd
CY2023	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-26146	usd
	bglc	Fair Value Loss FairValueLoss	63650	usd
CY2023	bglc	Fair Value Loss FairValueLoss	313859	usd
	bglc	Impairment On Other Investment ImpairmentOnOtherInvestment	0	usd
CY2023	bglc	Impairment On Other Investment ImpairmentOnOtherInvestment	-6194	usd
	bglc	Foreign Exchange Translation ForeignExchangeTranslation	204166	usd
CY2023	bglc	Foreign Exchange Translation ForeignExchangeTranslation	-53319	usd
	bglc	Other Investments Ening Balance OtherInvestmentsEningBalance	1994175	usd
	us-gaap	Revenues Revenues	6986791	usd
	us-gaap	Cost Of Revenue CostOfRevenue	6006504	usd
	us-gaap	Gross Profit GrossProfit	980287	usd
	us-gaap	Other Income OtherIncome	1397479	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	3535248	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1157482	usd
	us-gaap	Interest Expense InterestExpense	15334	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1172816	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	77207	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1250023	usd
	us-gaap	Revenues Revenues	7497739	usd
	us-gaap	Cost Of Revenue CostOfRevenue	6434796	usd
	us-gaap	Gross Profit GrossProfit	1062943	usd
	us-gaap	Other Income OtherIncome	511792	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	4426077	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2851342	usd
	us-gaap	Interest Expense InterestExpense	9746	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2861088	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	76418	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2937506	usd
CY2023Q4	us-gaap	Deposits Assets DepositsAssets	3305371	usd
CY2024Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	1425343	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	799674	usd
CY2024Q3	us-gaap	Other Receivables OtherReceivables	65683	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	122432	usd
CY2024Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	22132	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	57588	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	1389076	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1137770	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	7039453	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	8046800	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	232747	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	141544	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1511618	usd
CY2024Q3	us-gaap	Other Investments OtherInvestments	1994175	usd
CY2023Q4	us-gaap	Other Investments OtherInvestments	1699831	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3352993	usd
CY2024Q3	us-gaap	Assets Assets	10995055	usd
CY2023Q4	us-gaap	Assets Assets	11399793	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1033125	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1402180	usd
CY2024Q3	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	292135	usd
CY2023Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	180912	usd
CY2024Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	13646	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	12255	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	192013	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	111018	usd
CY2024Q3	us-gaap	Liabilities Liabilities	1606882	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000000	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	17332315	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	17191315	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	-5011891	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	-5011891	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3094301	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1844278	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-162050	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-677294	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	9388173	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	9657852	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10995055	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11399793	usd
	us-gaap	Profit Loss ProfitLoss	2937506	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	15620	usd
	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	122843	usd
	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	1372573	usd
	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	842401	usd
	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4175	usd
	bglc	Dividend Income DividendIncome	59653	usd
	bglc	Dividend Income DividendIncome	48892	usd
	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	63650	usd
	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	223284	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	-29140	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	0	usd
	us-gaap	Gain Loss On Sale Of Other Investments GainLossOnSaleOfOtherInvestments	35098	usd
	us-gaap	Gain Loss On Sale Of Other Investments GainLossOnSaleOfOtherInvestments	0	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	6974	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	6794	usd
	us-gaap	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-1841328	usd
	us-gaap	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-1145222	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	251306	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	130502	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-150638	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-505667	usd
	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	296109	usd
	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	494741	usd
	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	26854	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	78787	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-368824	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	6974	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	6794	usd
	bglc	Advances From Directors AdvancesFromDirectors	5362	usd
	bglc	Advances From Directors AdvancesFromDirectors	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1612	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5743206	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	449940	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-306677	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1792117	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4028019	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5929336	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2118864	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4137219	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6146883	usd
	bglc	Fixed Deposits Placed With Financial Institutions FixedDepositsPlacedWithFinancialInstitutions	2075503	usd
	bglc	Fixed Deposits Placed With Financial Institutions FixedDepositsPlacedWithFinancialInstitutions	1442098	usd
	bglc	Cash And Bank Balances CashAndBankBalances	2061716	usd
	bglc	Cash And Bank Balances CashAndBankBalances	4704785	usd
	us-gaap	Interest Paid Net InterestPaidNet	15334	usd
	us-gaap	Interest Paid Net InterestPaidNet	9746	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-39842	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-47808	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In preparing these condensed consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the periods reported. Actual results may differ from these estimates.</p>
	bglc	Trade Receivables Textblock TradeReceivablesTextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 3 - TRADE RECEIVABLES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has performed an analysis on all its trade receivables. As such, trade receivables are recognized and carried at the original invoice amount less an allowance for any uncollectible amounts. An estimate for doubtful debts and expected credit losses is made when collection of the full amount is no longer probable. Bad debts are written off as identified for the quarter ended September 30, 2024. The Company’s trade receivables consist of receivable from customers which are unrelated to the Company. The account receivables are interest bearing at a rate of 6% per annum on Interlink Techno started in May 2021 through June 2023. From July 2023 onwards, Chemrex had increased the interest to 8.4%. Chemrex imposed 6% per annum interest on Mawintech Sdn Bhd from May 2021 through the current date. The normal trade credit terms are generally 30 days to 90 days.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>As of</strong></p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Trade receivables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:12%;vertical-align:bottom;text-align:right;">2,072,588</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:12%;vertical-align:bottom;text-align:right;">2,107,182</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Allowances for expected credit losses</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">(596,332</td><td style="vertical-align:bottom;white-space: nowrap;">)</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">(1,314,427</td><td style="vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Foreign translation differences</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">(50,913</td><td style="PADDING-BOTTOM: 1px;vertical-align:bottom;white-space: nowrap;">)</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">(6,919</td><td style="PADDING-BOTTOM: 1px;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">1,425,343</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">799,674</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Movement for trade receivables allowance for impairment accounts:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>As of</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">At January 1, 2024 and January 1, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:12%;vertical-align:bottom;text-align:right;">1,307,508</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:12%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Impacts arising from application of Topic 326</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">371,627</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">At January 1, 2024 and January 1, 2023, (restated)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">1,307,508</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">371,627</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Charge for the period/year</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Allowances for expected credit losses</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">853,686</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">942,800</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Recovered for expected credit losses</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">(1,571,782</td><td style="vertical-align:bottom;white-space: nowrap;">)</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">-</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Foreign translation differences</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">57,832</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">(6,919</td><td style="PADDING-BOTTOM: 1px;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">647,244</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">1,307,508</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2024Q3	us-gaap	Trade Receivables Held For Sale Net Not Part Of Disposal Group TradeReceivablesHeldForSaleNetNotPartOfDisposalGroup	2072588	usd
CY2023Q4	bglc	Income Taxs Liability IncomeTaxsLiability	-45333	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	141544	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	55730	usd
CY2024Q3	bglc	Operating Lease Right Of Use Liabilities OperatingLeaseRightOfUseLiabilities	142865	usd
CY2024Q3	bglc	Operating Lease Right Of Use Asset Additional OperatingLeaseRightOfUseAssetAdditional	142865	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2505131	usd
CY2023Q4	bglc	Add Foreign Translation Differences AddForeignTranslationDifferences	-225889	usd
CY2023	bglc	Other Investments Ening Balance OtherInvestmentsEningBalance	1699831	usd
CY2024Q1	bglc	Contract Termination Amount ContractTerminationAmount	109000	usd
CY2024Q1	bglc	Contract Settlement Amount ContractSettlementAmount	76000	usd
CY2024Q2	bglc	Contract Refund Paid To Supplier ContractRefundPaidToSupplier	350000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001737523
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	141544	usd
	bglc	Gain On Lease Termination GainOnLeaseTermination	0	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41750
	dei	Entity Registrant Name EntityRegistrantName	BioNexus Gene Lab Corp.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WY
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	35-2604830
	dei	Entity Address Address Line1 EntityAddressAddressLine1	Unit:A-28-7, Tower A
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Menara UOA Bangsar
	dei	Entity Address Address Line3 EntityAddressAddressLine3	No.5 Jln Bangsar Utama 1
	dei	Entity Address City Or Town EntityAddressCityOrTown	Kuala Lumpur
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	59200
	dei	City Area Code CityAreaCode	307
	dei	Local Phone Number LocalPhoneNumber	241 6898
	dei	Security12b Title Security12bTitle	Common stock, no par value
	dei	Trading Symbol TradingSymbol	BGLC
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17967663	shares
CY2024Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	2061716	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	2623965	usd
CY2024Q3	us-gaap	Deposits Assets DepositsAssets	2075503	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1728680	usd
CY2024Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	3955602	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	48214	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	34632	usd
CY2024Q3	us-gaap	Customer Advances Current CustomerAdvancesCurrent	22834	usd
CY2023Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	0	usd
CY2024Q3	bglc	Amount Owing To Director AmountOwingToDirector	18561	usd
CY2023Q4	bglc	Amount Owing To Director AmountOwingToDirector	13199	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1414869	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1630923	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	178367	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	98763	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1741941	usd
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17967663	shares
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17667663	shares
CY2024Q3	us-gaap	Revenues Revenues	2630376	usd
CY2023Q3	us-gaap	Revenues Revenues	2553686	usd
	us-gaap	Revenues Revenues	6986791	usd
	us-gaap	Revenues Revenues	7497739	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	2303840	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	2199354	usd
	us-gaap	Cost Of Revenue CostOfRevenue	6006504	usd
	us-gaap	Cost Of Revenue CostOfRevenue	6434796	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	326536	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	354332	usd
	us-gaap	Gross Profit GrossProfit	980287	usd
	us-gaap	Gross Profit GrossProfit	1062943	usd
CY2024Q3	us-gaap	Other Income OtherIncome	465527	usd
CY2023Q3	us-gaap	Other Income OtherIncome	199284	usd
	us-gaap	Other Income OtherIncome	1397479	usd
	us-gaap	Other Income OtherIncome	511792	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2129685	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3082128	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3535248	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4426077	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1337622	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2528512	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1157482	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2851342	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	6193	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	4259	usd
	us-gaap	Interest Expense InterestExpense	15334	usd
	us-gaap	Interest Expense InterestExpense	9746	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1343815	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2532771	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1172816	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2861088	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1555	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	76418	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	77207	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	76418	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1345370	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2609189	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1250023	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2937506	usd
CY2024Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1046789	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-18603	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	839344	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-391533	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-298581	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2627792	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-410679	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3329039	usd
CY2024Q3	bglc	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.017
CY2023Q3	bglc	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.157
	bglc	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.023
	bglc	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.218
CY2024Q3	bglc	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	17967663	shares
CY2023Q3	bglc	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	16774370	shares
	bglc	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	17768393	shares
	bglc	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	15250883	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6665013	usd
CY2023Q1	bglc	Impacts Arising From Application Of Topic ImpactsArisingFromApplicationOfTopic	-371627	usd
CY2023Q1	bglc	Stockholders Equity Restated StockholdersEquityRestated	6293386	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-69066	usd
CY2023Q1	bglc	Foreign Currency Translation Loss ForeignCurrencyTranslationLoss	-39039	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	6185281	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-259251	usd
CY2023Q2	bglc	Foreign Currency Translation Loss ForeignCurrencyTranslationLoss	-333891	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	5592139	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2609189	usd
CY2023Q3	bglc	Round Up Shares Amount RoundUpSharesAmount	1046	usd
CY2023Q3	bglc	Issuance Of Shares Amount IssuanceOfSharesAmount	5750000	usd
CY2023Q3	bglc	Issuance Of Sharesone Amount IssuanceOfSharesoneAmount	600695	usd
CY2023Q3	bglc	Foreign Currency Translation Loss ForeignCurrencyTranslationLoss	-18603	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	9316088	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	9657852	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-103757	usd
CY2024Q1	bglc	Foreign Currency Translation Loss ForeignCurrencyTranslationLoss	-209908	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	9344187	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	199104	usd
CY2024Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2463	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	9545754	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-1345370	usd
CY2024Q3	bglc	Issuance Of Shares Amount IssuanceOfSharesAmount	141000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1046789	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	9388173	usd
	us-gaap	Profit Loss ProfitLoss	1250023	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	35507	usd
	us-gaap	Depreciation Depreciation	74611	usd
	us-gaap	Depreciation Depreciation	63147	usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	578	usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	usd
	bglc	Property Plant And Equipment Written Off PropertyPlantAndEquipmentWrittenOff	0	usd
	bglc	Property Plant And Equipment Written Off PropertyPlantAndEquipmentWrittenOff	18	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	141000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	601741	usd
	bglc	Stock Written Off StockWrittenOff	0	usd
	bglc	Stock Written Off StockWrittenOff	392	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-257832	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-364617	usd
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	22834	usd
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-14905	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-24342	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	81989	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-36847	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-27904	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2164489	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1039686	usd
	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	486170	usd
	bglc	Proceeds Of Dividend Income ProceedsOfDividendIncome	-59653	usd
	bglc	Proceeds Of Dividend Income ProceedsOfDividendIncome	-48892	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	222967	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	148461	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-75956	usd
	bglc	Payment Of Shares Subscriptions PaymentOfSharesSubscriptions	0	usd
	bglc	Payment Of Shares Subscriptions PaymentOfSharesSubscriptions	5750000	usd
	bglc	Cash And Cash Equivalents End Of Financial Period CashAndCashEquivalentsEndOfFinancialPeriod	4137219	usd
	bglc	Cash And Cash Equivalents End Of Financial Period CashAndCashEquivalentsEndOfFinancialPeriod	6146883	usd
	bglc	Income Tax Refunded IncomeTaxRefunded	0	usd
	bglc	Income Tax Refunded IncomeTaxRefunded	315	usd
	bglc	Expectedcreditlosses Policy Textblock ExpectedcreditlossesPolicyTextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company estimates and records a provision for its expected credit losses related to its financial instruments, including its trade receivables. Management considers historical collection rates, the current financial status of the Company’s customers, macroeconomic factors, and other industry-specific factors when evaluating current expected credit losses. Forward-looking information is also considered in the evaluation of current expected credit losses.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">To determine the provision for credit losses for accounts receivable, the Company has disaggregated its accounts receivable by business component, as management determined that risk profile of the Company’s customers is consistent based on the type and industry in which they operate. Each business component is analyzed for estimated credit losses individually. In doing so, the Company establishes a historical loss matrix, based on the previous collections of accounts receivable by the age of such receivables. Further, the Company considers macroeconomic factors and the status of the industry the business component is in to estimate if there are current expected credit losses within its trade receivables based on the trends of the Company’s expectation of the future status of such economic and industry-specific factors. Also, specific allowance amounts are established based on review of outstanding invoices to record the appropriate provision for customers that have a higher probability of default.</p>
	bglc	Nine Months Usmyrexchangerate NineMonthsUsmyrexchangerate	4.6327
	bglc	Nine Months Usmyrexchangerate NineMonthsUsmyrexchangerate	4.5192
	bglc	Trade Receivables Description TradeReceivablesDescription	The Company’s trade receivables consist of receivable from customers which are unrelated to the Company. The account receivables are interest bearing at a rate of 6% per annum on Interlink Techno started in May 2021 through June 2023
CY2024Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	22132	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	57588	usd
	bglc	Less Lease Termination LessLeaseTermination	-24759	usd
CY2023	bglc	Less Lease Termination LessLeaseTermination	0	usd
	bglc	Rented Term RentedTerm	P5Y
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	15620	usd
CY2024Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	24759	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	25337	usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	578	usd
	bglc	Gain On Lease Termination GainOnLeaseTermination	578	usd
CY2024Q3	bglc	Buildings Gross BuildingsGross	1075814	usd
	bglc	Exchange For The Transfer Of Machinery ExchangeForTheTransferOfMachinery	190341	usd
CY2024Q3	us-gaap	Investments Investments	242721	usd
CY2023Q4	us-gaap	Investments Investments	0	usd
	bglc	Outlined For Deposits OutlinedForDeposits	1067433	usd
	bglc	Initial Payment For The Transactions Of Agreement InitialPaymentForTheTransactionsOfAgreement	10674	usd
	bglc	Purchase Of Materials PurchaseOfMaterials	170460	usd
	us-gaap	Other Expenses OtherExpenses	916954	usd

Files In Submission

Name	View Source	Status
0001477932-24-007332-index-headers.html	Edgar Link	pending
0001477932-24-007332-index.html	Edgar Link	pending
0001477932-24-007332.txt	Edgar Link	pending
0001477932-24-007332-xbrl.zip	Edgar Link	pending
bglc-20240930.xsd	Edgar Link	pending
bglc_10q.htm	Edgar Link	pending
bglc_ex311.htm	Edgar Link	pending
bglc_ex312.htm	Edgar Link	pending
bglc_ex321.htm	Edgar Link	pending
bglc_ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
bglc-20240930_cal.xml	Edgar Link	unprocessable
bglc-20240930_def.xml	Edgar Link	unprocessable
bglc-20240930_lab.xml	Edgar Link	unprocessable
bglc-20240930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bglc_10q_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BGLC
BioNexus Gene Lab Corp Stock $bglc

2024 Q4 Form 10-Q Financial Statement

#000147793224007332 Filed on November 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BGLC BioNexus Gene Lab Corp Stock $bglc

2024 Q4 Form 10-Q Financial Statement

#000147793224007332 Filed on November 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BGLC
BioNexus Gene Lab Corp Stock $bglc